TB-500 (Thymosin Beta-4) is a synthetic research peptide studied in preclinical research for its potential to support healing, recovery, and cellular regeneration. Preclinical research suggests it may promote tissue repair by enhancing cell migration, blood vessel formation, and inflammation control. Studies have also explored its potential to accelerate recovery in muscle, tendon, and ligament models, as well as support cardiovascular and wound-healing processes.
For research use only — not for human consumption, medical, or therapeutic use.
